Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4094PDF: 3375HTML: 202 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3238PDF: 1079HTML: 431 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3245PDF: 1709HTML: 1083 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1362PDF: 753HTML: 942 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1983PDF: 1121HTML: 615 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
2022PDF: 1052HTML: 708Figure 1: 153Figure 2: 166 -
IMMUNOLOGY OF TUBERCULOSIS
5267PDF: 2000HTML: 7318Untitled: 195 -
AN INEXPENSIVE CLINICAL-LABORATORY NOMOGRAM TO PREDICT POST-TREATMENT LUNG DESTRUCTION IN PULMONARY TUBERCULOSIS
553PDF: 260Suppl. Files: 69Html: 42 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1202PDF: 710HTML: 1230 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6925PDF: 3911HTML: 24880 -
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2640PDF: 1074HTML: 113 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
721PDF: 833PDF Supp. Files: 76HTML: 186 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4235PDF: 1514HTML: 445 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1171PDF: 828HTML: 3358 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1052PDF: 960HTML: 325 -
THE ROLE OF SERIAL RADIOGRAPHS TO DIAGNOSE DIABETIC FOOT BONE INFECTION. Serial radiographs and diabetic foot osteomyelitis
1355PDF: 693HTML: 205 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3316PDF: 582HTML: 655 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1599PDF: 795HTML: 1228Figure 1: 172Figure 2: 184Figure 3: 182 -
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1354PDF: 1032HTML: 4602 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1124PDF: 515HTML: 189 -
POST-LOAD PLASMA GLUCOSE INCREASE (PG-GAP) AS A RISK FACTOR FOR DEVELOPING DYSGLYCEMIA IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (Β-TDT): RETROSPECTIVE ANALYSIS OVER 8 YEARS Post load plasma glucose increase and the risk of glucose dysregulation in thalassemia
488PDF: 238HTML: 42 -
-
Simultaneous dual pathology in lymph node
1646PDF: 691HTML: 7691Simultaneous dual pathology in lymph node: 173Simultaneous dual pathology in lymph node: 171Simultaneous dual pathology in lymph node: 149Simultaneous dual pathology in lymph node: 188Simultaneous dual pathology in lymph node: 173 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3368PDF: 1290HTML: 1861Fig.1: 199Fig. 2: 205 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2385PDF: 910HTML: 484 -
Acquired Hemophilia A successfully treated with rituximab
1927PDF: 1142HTML: 1456Figure 1: 174 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
991PDF: 534HTML: 7809 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
694PDF: 373Suppl. Files: 118HTML: 111







